Effect of intravenous pyridoxine on plasma prolactin in hyperprolactinemic subjects

Allen M. Spiegel; Saul W. Rosen; Bruce D. Weintraub; Samuel P. Marynick

doi:10.1210/jcem-46-4-686

Effect of intravenous pyridoxine on plasma prolactin in hyperprolactinemic subjects

Allen M. Spiegel, Saul W. Rosen, Bruce D. Weintraub, Samuel P. Marynick

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Intravenous pyridoxine has been reported to lower plasma PRL in normal subjects and in patients with the amenorrhea-galactorrhea syndrome. We tested the effect of pyridoxine (300-mg iv bolus) on plasma PRL in nine patients with hyperprolactinemia due to a variety of causes. There was no effect of pyridoxine on elevated plasma PRL in any of the nine hyperprolactinemic subjects. The potential utility of pyridoxine in the long term treatment of the galactorrhea-amenorrhea syndrome will require further study. and; 1978 BY THE ENDOCRINE SOCIETY.

Original language	English (US)
Pages (from-to)	686-688
Number of pages	3
Journal	Journal of Clinical Endocrinology and Metabolism
Volume	46
Issue number	4
DOIs	https://doi.org/10.1210/jcem-46-4-686
State	Published - Apr 1978
Externally published	Yes

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Biochemistry
Endocrinology
Clinical Biochemistry
Biochemistry, medical

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1210/jcem-46-4-686

Cite this

@article{3ef2ed4450f94cc39b852cd9ce2caf2b,

title = "Effect of intravenous pyridoxine on plasma prolactin in hyperprolactinemic subjects",

abstract = "Intravenous pyridoxine has been reported to lower plasma PRL in normal subjects and in patients with the amenorrhea-galactorrhea syndrome. We tested the effect of pyridoxine (300-mg iv bolus) on plasma PRL in nine patients with hyperprolactinemia due to a variety of causes. There was no effect of pyridoxine on elevated plasma PRL in any of the nine hyperprolactinemic subjects. The potential utility of pyridoxine in the long term treatment of the galactorrhea-amenorrhea syndrome will require further study. and; 1978 BY THE ENDOCRINE SOCIETY.",

author = "Spiegel, {Allen M.} and Rosen, {Saul W.} and Weintraub, {Bruce D.} and Marynick, {Samuel P.}",

year = "1978",

month = apr,

doi = "10.1210/jcem-46-4-686",

language = "English (US)",

volume = "46",

pages = "686--688",

journal = "Journal of Clinical Endocrinology and Metabolism",

issn = "0021-972X",

publisher = "The Endocrine Society",

number = "4",

}

TY - JOUR

T1 - Effect of intravenous pyridoxine on plasma prolactin in hyperprolactinemic subjects

AU - Spiegel, Allen M.

AU - Rosen, Saul W.

AU - Weintraub, Bruce D.

AU - Marynick, Samuel P.

PY - 1978/4

Y1 - 1978/4

N2 - Intravenous pyridoxine has been reported to lower plasma PRL in normal subjects and in patients with the amenorrhea-galactorrhea syndrome. We tested the effect of pyridoxine (300-mg iv bolus) on plasma PRL in nine patients with hyperprolactinemia due to a variety of causes. There was no effect of pyridoxine on elevated plasma PRL in any of the nine hyperprolactinemic subjects. The potential utility of pyridoxine in the long term treatment of the galactorrhea-amenorrhea syndrome will require further study. and; 1978 BY THE ENDOCRINE SOCIETY.

AB - Intravenous pyridoxine has been reported to lower plasma PRL in normal subjects and in patients with the amenorrhea-galactorrhea syndrome. We tested the effect of pyridoxine (300-mg iv bolus) on plasma PRL in nine patients with hyperprolactinemia due to a variety of causes. There was no effect of pyridoxine on elevated plasma PRL in any of the nine hyperprolactinemic subjects. The potential utility of pyridoxine in the long term treatment of the galactorrhea-amenorrhea syndrome will require further study. and; 1978 BY THE ENDOCRINE SOCIETY.

UR - http://www.scopus.com/inward/record.url?scp=0018181205&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018181205&partnerID=8YFLogxK

U2 - 10.1210/jcem-46-4-686

DO - 10.1210/jcem-46-4-686

M3 - Article

C2 - 755053

AN - SCOPUS:0018181205

SN - 0021-972X

VL - 46

SP - 686

EP - 688

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

IS - 4

ER -

Effect of intravenous pyridoxine on plasma prolactin in hyperprolactinemic subjects

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this